INS and metabolic dysfunction-associated steatotic liver disease: As shown in Supplementary Table S6, both the average fasting insulin and insulin resistance index of the NAFLD patients in the obesity group were significantly higher than those in the lean group (B1 vs. B2, p < 0.05).